174 related articles for article (PubMed ID: 30579124)
1. Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis.
Aneja B; Khan NS; Khan P; Queen A; Hussain A; Rehman MT; Alajmi MF; El-Seedi HR; Ali S; Hassan MI; Abid M
Eur J Med Chem; 2019 Feb; 163():840-852. PubMed ID: 30579124
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
Parveen I; Khan P; Ali S; Hassan MI; Ahmed N
Eur J Med Chem; 2018 Nov; 159():166-177. PubMed ID: 30290280
[TBL] [Abstract][Full Text] [Related]
3. Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.
Voura M; Khan P; Thysiadis S; Katsamakas S; Queen A; Hasan GM; Ali S; Sarli V; Hassan MI
Sci Rep; 2019 Feb; 9(1):1676. PubMed ID: 30737440
[TBL] [Abstract][Full Text] [Related]
4. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents.
Ibrahim HS; Abou-Seri SM; Ismail NSM; Elaasser MM; Aly MH; Abdel-Aziz HA
Eur J Med Chem; 2016 Jan; 108():415-422. PubMed ID: 26706352
[TBL] [Abstract][Full Text] [Related]
5. Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4.
Khan P; Queen A; Mohammad T; Smita ; Khan NS; Hafeez ZB; Hassan MI; Ali S
J Nat Prod; 2019 Aug; 82(8):2252-2261. PubMed ID: 31343173
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays.
Naz F; Sami N; Naqvi AT; Islam A; Ahmad F; Imtaiyaz Hassan M
J Biomol Struct Dyn; 2017 Nov; 35(14):3194-3203. PubMed ID: 27748164
[TBL] [Abstract][Full Text] [Related]
7. Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression.
Naz F; Khan FI; Mohammad T; Khan P; Manzoor S; Hasan GM; Lobb KA; Luqman S; Islam A; Ahmad F; Hassan MI
Int J Biol Macromol; 2018 Feb; 107(Pt B):2580-2589. PubMed ID: 29079437
[TBL] [Abstract][Full Text] [Related]
8. A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor.
Al-Salem HS; Arifuzzaman M; Alkahtani HM; Abdalla AN; Issa IS; Alqathama A; Albalawi FS; Rahman AFMM
Molecules; 2020 Sep; 25(19):. PubMed ID: 32992673
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and apoptosis inducing studies of triazole linked 3-benzylidene isatin derivatives.
Nagarsenkar A; Guntuku L; Guggilapu SD; K DB; Gannoju S; Naidu VGM; Bathini NB
Eur J Med Chem; 2016 Nov; 124():782-793. PubMed ID: 27639369
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells.
Yu B; Wang SQ; Qi PP; Yang DX; Tang K; Liu HM
Eur J Med Chem; 2016 Nov; 124():350-360. PubMed ID: 27597411
[TBL] [Abstract][Full Text] [Related]
11. Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition.
Anwar S; Shamsi A; Shahbaaz M; Queen A; Khan P; Hasan GM; Islam A; Alajmi MF; Hussain A; Ahmad F; Hassan MI
Sci Rep; 2020 Jun; 10(1):10300. PubMed ID: 32587267
[TBL] [Abstract][Full Text] [Related]
12. Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma.
Ahmed S; Queen A; Irfan I; Siddiqui MN; Abdulhameed Almuqdadi HT; Setia N; Ansari J; Hussain A; Hassan MI; Abid M
ACS Omega; 2024 Jun; 9(24):25945-25959. PubMed ID: 38911744
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity.
Ammar YA; Sh El-Sharief AM; Belal A; Abbas SY; Mohamed YA; Mehany ABM; Ragab A
Eur J Med Chem; 2018 Aug; 156():918-932. PubMed ID: 30096580
[TBL] [Abstract][Full Text] [Related]
14. Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition.
Naz F; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
OMICS; 2015 Nov; 19(11):700-11. PubMed ID: 26565604
[TBL] [Abstract][Full Text] [Related]
15. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies.
Khan P; Rahman S; Queen A; Manzoor S; Naz F; Hasan GM; Luqman S; Kim J; Islam A; Ahmad F; Hassan MI
Sci Rep; 2017 Aug; 7(1):9470. PubMed ID: 28842631
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro antiproliferative activity of novel isatin-quinazoline hybrids.
Fares M; Eldehna WM; Abou-Seri SM; Abdel-Aziz HA; Aly MH; Tolba MF
Arch Pharm (Weinheim); 2015 Feb; 348(2):144-54. PubMed ID: 25664631
[TBL] [Abstract][Full Text] [Related]
18. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 4-(2-(dimethylamino)ethoxy)benzohydrazide derivatives as prospective microtubule affinity regulating kinase 4 inhibitors.
Khan NS; Khan P; Inam A; Ahmad K; Yousuf M; Islam A; Ali S; Azam A; Husain M; Hassan MI
RSC Adv; 2020 May; 10(34):20129-20137. PubMed ID: 35520423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]